Evergreen Wealth Solutions, LLC Novo Nordisk A S Transaction History

Evergreen Wealth Solutions, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $14,725 - $17,629	-120 Reduced 7.14%	1,561 $222,000
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $171,646 - $228,481	1,681 New	1,681 $215,000
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $22,630 - $27,212	-171 Reduced 11.03%	1,380 $220,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $159,055 - $209,896	1,551 New	1,551 $210,000
Q1 2022 Apr 22, 2022	SELL	$93.1 - $112.54 $167,766 - $202,797	-1,802 Closed	0 $0
Q4 2021 Jan 19, 2022	BUY	$95.88 - $117.08 $172,775 - $210,978	1,802 New	1,802 $202,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Evergreen Wealth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Evergreen Wealth Solutions, LLC with notifications on news.